| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 94,500 | 94,895 | 92,207 | 112,330 | | Cost of Revenue | (5,979) | 83,026 | 81,662 | 91,089 | | | Gross Profit | 100,479 | 11,869 | 10,545 | 21,241 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,832 | 14,082 | 14,610 | 16,636 | | Non Recurring | 252 | (118) | (134) | (257) | | Others | 4,303 | 4,403 | 4,590 | 4,668 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,833) | (6,498) | (8,521) | 194 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (30) | (177) | (304) | 282 | | Earnings Before Interest And Taxes | (4,625) | (6,572) | (8,769) | 842 | | Interest Expense | 5 |
-
| 4 | 30 | | Income Before Tax | (4,630) | (6,572) | (8,773) | 812 | | Income Tax Expense | (2,070) | (1,404) | (2,652) | 1,013 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,088) | (5,168) | (6,121) | (201) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,560) | (5,168) | (6,121) | (201) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,560) | ($5,168) | ($6,121) | ($201) |
|
0.22% Nasdaq 
0.02 (0.62%) 
Income Statement
